<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-X06WIKHW</identifier><date>2023</date><creator>Bačar, Cvetka</creator><relation>documents/doc/X/URN_NBN_SI_doc-X06WIKHW_001.pdf</relation><relation>documents/doc/X/URN_NBN_SI_doc-X06WIKHW_001.txt</relation><format format_type="issue">2</format><format format_type="volume">74</format><format format_type="type">article</format><format format_type="extent">str. 131-135</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID">189913603</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-X06WIKHW</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">klinični farmacevt</subject><subject language_type_id="slv">multidisciplinarna obravnava</subject><subject language_type_id="slv">postcovidni sindrom</subject><subject language_type_id="slv">svetovanje</subject><title>Individualna izbira antidepresivov pri bolnikih s postcovidnim sindromom – prikaz dveh kliničnih primerov</title><title>Individual choice of antidepressants in patients with postcovid syndrome - two clinical cases</title></Record>